News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Zelira Therapeutics.
RELATED STOCKHEAD STORIES
News
Closing Bell: Zip abandons Sezzle at altar as ‘sell now, maybe come back later’ trade hits small caps
Health & Biotech
Weed Week: Cannabis lounges in Las Vegas and Cann’s Mildura cannabis facility gets GMP licence
Health & Biotech
Weed Week: Cannabis-feed for chickens and cannabis campaigner nabs Queen’s Birthday honour
News
Market highlights and 5 ASX small caps to watch on Wednesday
Health & Biotech
Could Aussie cannabinoid companies help solve a global opioid crisis?
Health & Biotech
ASX Health Stocks: Invion demonstrates efficacy, Biotron gets feedback from the FDA
Health & Biotech
Weed Week: Woody Harrelson opens weed dispensary and Byron Bay could be home to a cannabis resort
Health & Biotech
ASX Health Stocks: Nyrada gets closer to European patent, and HOPE for Zelira’s autism tincture
News
Market Highlights and 5 ASX Small Caps to watch on Tuesday
Health & Biotech
Weed Week: US seed bank launches 4/20 day NFT collection and Washington has a cannabis tax holiday
Health & Biotech
ASX Health Stocks: Here’s a highlight from today’s half-year result announcements
Health & Biotech
Weed Week: Cannabis compounds could prevent Covid and Quebec’s no-jab, no-weed rule quadruples vaccinations
Health & Biotech
ASX Health Stocks: Immuron up 29pc on $6.2m travellers’ diarrhoea clinical study for US military
Health & Biotech
ASX Health Stocks: CSL drags Healthcare index down 5pc on a mammoth $6.3bn cap raise
News
Market Highlights and 5 ASX Small Caps to watch on Thursday
Health & Biotech
ASX Health Stocks: Paradigm rockets 21pc after getting FDA nod, Memphasys up 31pc on imminent launch
News
